ARCHIVES

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

Chemo Combinations Tested In Phase III For Lung Cancer

August 31, 2001

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985